{"id":29192,"date":"2025-07-01T06:46:12","date_gmt":"2025-07-01T06:46:12","guid":{"rendered":"https:\/\/www.europesays.com\/us\/29192\/"},"modified":"2025-07-01T06:46:12","modified_gmt":"2025-07-01T06:46:12","slug":"more-days-more-resistance-time-to-rethink-antibiotics","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/us\/29192\/","title":{"rendered":"More Days, More Resistance: Time to Rethink Antibiotics"},"content":{"rendered":"<p>\u201cOne of the most universally accepted beliefs around the world,\u201d said Brad Spellberg, MD, chief medical officer at Los Angeles General Medical Center, \u201cis that when you take antibiotics, you must complete the prescribed course \u2014 7, 10, or 14 days \u2014 even after you start feeling better, in order to eliminate every last bacterium and prevent a future relapse.\u201d<\/p>\n<p>\u201cBut that recommendation doesn\u2019t make sense. There\u2019s no data to support it,\u201d Spellberg noted in a <a href=\"https:\/\/www.eventgo.ar\/SADI2025\/ProgramaWEB.dll#itemDia2\" rel=\"nofollow noopener\" target=\"_blank\">virtual lecture<\/a> at the 2025 Argentine Society of Infectious Diseases Congress, held in Mar del Plata from June 12 to 14.<\/p>\n<p>\u201cThat\u2019s not how antibiotics work. Every additional day you take an antibiotic increases resistance,\u201d he emphasized.<\/p>\n<p>Spellberg cited two quotes from Louis Rice, MD, chair of the Department of Medicine at the Warren Alpert Medical School of Brown University, Providence, Rhode Island, and former president of the Infectious Diseases Society of America:<\/p>\n<ul>\n<li>\u201cThe most viable strategy for reducing antimicrobial selective pressure is to treat infections only for as long as is necessary.\u201d<\/li>\n<li>\u201c[Completing the prescribed antibiotic regimen] may be excellent advice when one wants to have patients take an adequate course to treat an infection, but it is poor advice for preventing resistance.\u201d<\/li>\n<\/ul>\n<p>\u201cWe should tell patients: \u2018If you\u2019re taking antibiotics, and you feel better but still have a few days left, call me, and we\u2019ll decide whether to stop,\u2019\u201d Spellberg advised.<\/p>\n<p>He added that if you prescribe 14 days of antibiotics for an infection, the patient is still taking them for a week after symptoms resolve. \u201cBut if you prescribe 5-7 days, stopping early isn\u2019t a problem. So, we can resolve everything simply by switching to short-course therapy.\u201d<\/p>\n<p><strong>\u2018Shorter Is Better\u2019<\/strong><\/p>\n<p>Spellberg\u2019s stance isn\u2019t new. A decade ago, he coined the mantra \u201c<a href=\"https:\/\/jamanetwork.com\/journals\/jamainternalmedicine\/article-abstract\/2536180\" rel=\"nofollow noopener\" target=\"_blank\">shorter is better<\/a>,\u201d challenging the dogma that longer antibiotic regimens are more effective \u2014 a notion since disproven by dozens of clinical trials. As he <a href=\"https:\/\/www.medscape.com\/viewarticle\/871856?_gl=1*9ci3qz*_gcl_au*MTYyMTY2MDQxOS4xNzUwMDY3NTEx\" rel=\"nofollow noopener\" target=\"_blank\">told Medscape\u2019s Spanish edition<\/a> in 2016, \u201cProviding short antibiotic courses based on evidence reduces the risk that patients will feel better before completing therapy and minimizes leftover pills.\u201d<\/p>\n<p>He reported that over 150 randomized controlled trials across 24 infection types have demonstrated that short antibiotic courses yield the same clinical outcomes as longer ones. For example, in cases of community-acquired pneumonia, 14 studies have shown that 3-5 days of antibiotic therapy are as effective as 5-14 days. Similarly, for urinary tract infections or pyelonephritis, 13 studies indicate that 5-7 days of treatment are just as effective as 10-14 days. In intra-abdominal infections, three studies have found that 4 days of antibiotics are comparable in efficacy to 8-10 days of treatment.<\/p>\n<p>However, in suspected cases of ventilator-associated pneumonia (not microbiologically confirmed), a <a href=\"https:\/\/academic.oup.com\/cid\/article\/64\/7\/870\/2756965?login=false\" rel=\"nofollow noopener\" target=\"_blank\">retrospective study<\/a> could not establish a difference between \u201cultrashort\u201d 3-day regimens and those lasting 2-3 weeks. \u201cIf you&#8217;re going to treat patients without infection with antibiotics,\u201d he added, \u201cat least keep it brief.\u201d<\/p>\n<p><strong>Paradigm Shift in Practice<\/strong><\/p>\n<p>Ezequiel C\u00f3rdova, MD, session moderator and infectious diseases specialist at Hospital Cosme Argerich and HIV clinical investigator at Fundaci\u00f3n IDEAA in Buenos Aires, Argentina, noted that Spellberg\u2019s message challenges a long-standing dogma passed down through generations regarding standard antibiotic durations.<\/p>\n<p>\u201cLately, we\u2019ve seen that shorter treatments can be just as effective,\u201d C\u00f3rdova told Medscape\u2019s Spanish edition. \u201cThat not only reduces adverse effects but also limits resistance. Treatments should be as long as necessary \u2014 no more, no less.\u201d<\/p>\n<p>He noted that soft tissue infections were once routinely treated with 14-day courses, \u201cbut today, if we see clinical improvement after 5 days, the treatment can be safely stopped. The same applies to pneumonia. Previously it was 10-14 days of antibiotics, but now 5 days is often enough if the patient improves.\u201d<\/p>\n<p>When asked whether further shortening is feasible in current practice, C\u00f3rdova replied, \u201cThere may be a limit where shorter durations compromise clinical outcomes \u2014 but we haven\u2019t reached it yet. We need to keep educating.\u201d<\/p>\n<p>Spellberg and C\u00f3rdova declared having no relevant financial conflicts of interest.\u00a0<\/p>\n<p>This story was translated from <a href=\"https:\/\/espanol.medscape.com\/verarticulo\/5914289#vp_1\" rel=\"nofollow noopener\" target=\"_blank\">Medscape\u2019s Spanish edition<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"\u201cOne of the most universally accepted beliefs around the world,\u201d said Brad Spellberg, MD, chief medical officer at&hellip;\n","protected":false},"author":3,"featured_media":29193,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[34],"tags":[25008,6014,25002,23051,25001,23053,25004,25009,25010,3738,25013,25012,440,4460,210,1060,25007,25011,25003,6015,25015,25014,25005,67,132,68,25006],"class_list":{"0":"post-29192","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-medication","8":"tag-abdominal","9":"tag-adverse-effects","10":"tag-antibiotic-overuse","11":"tag-antibiotic-resistance","12":"tag-antibiotics","13":"tag-bacteria","14":"tag-bacterial-infection","15":"tag-clinical-research","16":"tag-clinical-studies","17":"tag-clinical-trials","18":"tag-double-blind-studies","19":"tag-double-blind-study","20":"tag-europe","21":"tag-european","22":"tag-health","23":"tag-medication","24":"tag-pneumonia","25":"tag-pre-clinical-trial","26":"tag-resistance-to-antibiotics","27":"tag-side-effects","28":"tag-single-blind-studies","29":"tag-single-blind-study","30":"tag-spain-spanish","31":"tag-united-states","32":"tag-unitedstates","33":"tag-us","34":"tag-ventilator-associated-pneumonia"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@us\/114776636389853345","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/29192","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/comments?post=29192"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/29192\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media\/29193"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media?parent=29192"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/categories?post=29192"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/tags?post=29192"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}